Global Launch of New Ultra-Portable Fundus Camera, from epipole, at Vision Expo East (NYC)


epiCam: the power of desktop retinal imaging, in the palm of your hand

Distributed via PRNewswire:

epipole, an emerging provider of world-class handheld fundus cameras, today announced the global launch of their new epiCam fundus camera to the US Eye Care market, at the Vision Expo East in New York City.

The epiCam is a high-powered, ultra-portable, wireless fundus camera, that captures live high-resolution video footage of the living retina, along with the accompanying still images, using epipole’s new video direct ophthalmoscopy (VDO) platform.

Speaking about the announcement, Conal Harte, CEO of epipole, says:
 “We are pleased to introduce our new epiCam to the US Eye Care community at Vision Expo East. We believe the opportunity to view the living retina with live video recording, as well as obtaining industry-standard high-resolution images, in a handheld device weighing just 1lb, is a compelling proposition for eye care professionals seeking to do faster & more in-depth eye exams.

It is epipole’s ambition to deliver outstanding technology that exceeds the expectation of our clinician customers, while ultimately enhancing the lives of their patients.”

epiCam: Handheld fundus Camera

  • Advanced Retinal Imaging, pan & tilt for super-wide field view
  • Dynamic imaging by live video recording of moving tissue & vasculature for detecting small, dynamic changes in ocular fundus
  • Accompanying review platform for review, storage, annotation, and retrieval of previous eye exams for comparison

Key Benefits

  • Image Quality: Multi-illuminant, live video, still images
  • Ease of Use: Handheld, “Always in focus” feature, light and ultra-portable (< 1lb)
  • Practice Efficiency: image directly in exam lane, compact design, remote support enabled
  • Review Station: Proprietary software for immediate review, annotation, retrieval, reporting and more

About epipole

epipole is a disruptive Scottish medical technology company that wants to make a difference in the eye care industry. Together we are solving the hard problems with taking images of the back of the eye, and our breakthrough Video Direct Ophthalmoscopy technology is challenging the way people view the retina.

epipole was founded by Dr Craig Robertson, an expert in imaging systems & algorithm development. 

New CEO and New Investment Prepare epipole for US Expansion


Press Release: ‘Retinal imaging specialist epipole is looking to kickstart its US growth ambitions following a £1.3 million funding round.

epipole has also appointed a new chief executive to take over from Craig Robertson, who set up the company in 2011 and is now moving into the position of chief technology officer. Conal Harte joins epipole from global orthopaedics company Ossur, where he was managing director of emerging markets.

The fresh funding round was led by Greenwood Way Capital – a network of funds, family offices and “ultra-high worth” individuals that co-invest in companies with disruptive technologies – and supported by Scottish Enterprise. Greenwood Way was also the primary backer in a previous £1.5m investment round closed by epipole in 2020.

The company’s hand-held epiCam allows clinicians to record scans of the retina using real-time video. Images are extracted from these videos for further examination, allowing for the earlier detection of disease.

“I am pleased to welcome Conal to the company,” epipole chairman Ian Stevens said. “He joins at a crucial moment in our development and brings significant commercial experience of growing disruptive medical technologies in international markets.”

The latest round of investment is supporting a recruitment drive in the US, where the company is aiming to launch its product into the primary care optometry and general ophthalmology markets. Mr Harte said he is “delighted” to be joining epipole at “such an exciting time” for the company.

“Our unique approach to retinal imaging will help our clinician customers deliver an outstanding level of eye care to patients through a market-leading technology that delivers exceptional imaging in a powerful, portable and low-cost device,” he said.

The company, which currently employs 12 people, was advised on the latest funding round by law firm Davidson Chalmers Stewart.

As published on the Scottish Hearld.  

epipole joins €1.1m AI project to diagnose intracranial pressure


epipole and Danish partners secure Eurostars grant funding to integrate handheld video ophthalmoscope technology with intracranial pressure measurement software

epipole, the video retinal imaging specialist, today announced that it has started work on a €1.1 million collaborative project to develop a technology solution for the diagnosis of intracranial pressure (ICP). The project is funded by the Eureka Eurostars programme, and is a collaboration between epipole, Denmark’s Statumanu ICP and the University of Southern Denmark.

Intracranial pressure is a growing pressure inside the skull, typically as the result of a brain injury or other medical condition. But injuries to the brain can be complicated to detect, and ICP is typically diagnosed via spinal tap (lumbar puncture), which is both invasive and expensive. Being able to quickly and easily measure changes in ICP in a non-invasive way is crucial to making the right decisions about a patient’s treatment.

The Eurostars project will combine epipole’s patented handheld video ophthalmoscope technology with Statumanu’s AI software, which can assess images of the blood vessels in the retina to provide instant assessment and continuous monitoring of changes in ICP.

epipole’s epiCam technology enables clinicians to scan the retina using real-time video and then extract high quality images. epiCam will be integrated with Statumanu’s AI software to capture the retinal data needed for the software to make the diagnosis.

“Having reviewed all the available retinal cameras on the market, epipole is the ideal partner for this project,” said Jakob Find Madsen, founder and CEO of Statumanu ICP. “As a lightweight, handheld camera that also shoots high resolution video, epiCam has all the capabilities needed to make this innovative system a success.”

“We’re thrilled to have secured Eurostars funding for this exciting collaboration with Statumanu,” said Dr Craig Robertson, founder and CEO of epipole. “We are looking forward to helping revolutionise the way in which intracranial pressure is diagnosed to support better clinical decision making and, ultimately, to improve patient outcomes.”

Following the completion of the technology integration, a clinical study to assess the effectiveness of the solution will be conducted at the University of Southern Denmark.

epipole secures £1.5 million investment


epipole has secured £1.5 million in funding to market its ground-breaking video retinal imaging device in the US. The funding round was led by new investor Greenwood Way Capital with the Scottish Investment Bank, the investment arm of Scottish Enterprise, also participating.

epipole also announced the appointment of medical technology veteran Ian Stevens as chairman.

epipole’s patented technology enables clinicians to scan the retina using real-time video and then extract high quality images for further examination. They are smaller and less expensive than conventional desktop systems.

Dr Craig Robertson, founder and CEO of epipole, said: “We’ve worked with ophthalmologists to test and refine features and capabilities, and will use this funding to implement the key changes needed”.

“We will have a particular focus on the US primary care optometry and ophthalmology markets, and plan to have product available by early 2021.”

“I am pleased to welcome Ian Stevens as chairman,” added Robertson. “His broad commercial experience and specific expertise in retinal imaging will be valuable to us as we introduce our products to the eyecare market.”

Stevens is an experienced technology industry executive, holding CEO positions at Scottish businesses Touch Bionics, Mpathy Medical and BioFilm. Previously, he spent nine years at leading retinal imaging company Optos, initially as CFO and then as General Manager of its North American business.

“There is a tremendous opportunity for handheld and truly portable fundus cameras that are easy to use and combine high quality imaging with attractive pricing,” said Stevens.

“I am delighted to join the company and look forward to working with Craig and his team as we seek to transform ophthalmic imaging with our new technology.”

epipole wins ophthalmology innovation challenge


epipole were selected as one of the five finalists in Novartis’ Biome 2019 Ophthalmology Innovation Challenge in their San Francisco Biome headquarters.

Among stiff competition from companies that presented their deeply innovative technology the six American Academy of Ophthalmology judges were unanimous in awarding epipole with the first prize of $6000. After a standing ovation one of the judges commented “Every GP in America should own your technology.”

Maybe one day they will.

epipole secures £1.5 million investment


epipole founder Craig Robertson discusses the history of the company and the challenges of balancing ‘doing the right thing’ with running a sustainable business in the latest edition of The Ophthalmologist.

Craig Robertson Speaks at TEDxGlasgow


350 Million Reasons to Disrupt the Medical Device Industry – Craig Robertson at TEDxGlasgow 2016

Retinal healthcare in motion.

Connect with us on social media or contact us

Get in Touch

Let us know how we can help and we’ll respond shortly.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.